Company Search:
Advanced Search
Sponsored Links
Pro-Dex, Inc. Company Snapshot
Pro-Dex, Inc. operates in the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pro-Dex with three other companies in this sector in the United States: Alliqua Biomedical Inc (2016 sales of $18.24 million ), Sonoma Pharmaceuticals Inc ($15.08 million of which 100% was Drugs & Devices), and CAS Medical Systems, Inc. ($22.24 million of which 81% was Tisssue Oximetry Monitoring).

Sales Analysis. Pro-Dex reported sales of $20.16 million for the fiscal year ending June of 2016. This represents an increase of 50.6% versus 2015, when the company's sales were $13.38 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pro-Dex, Inc.
  Stock Performance Chart for Pro-Dex, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 6.30
(Figures in U.S. Dollars)
1 Week 5.0%   13 Weeks 11.5%  
4 Weeks 37.0%   52 Weeks 13.5%  
Pro-Dex, Inc. Key Data:
  Ticker: PDEX Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2016 Sales 20,158,000
(Year Ending Jan 2017).
Employees: 67
  Currency: U.S. Dollars Market Cap: 25,289,372
  Fiscal Yr Ends: June Shares Outstanding: 4,014,186
  Share Type: Common Closely Held Shares: 1,169,216
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.